VJOncology is committed to improving our service to you

GU Cancers 2019 | Combined blockade of VEGF and PD-1 signaling in RCC

VJOncology is committed to improving our service to you

Michael Atkins

Michael Atkins, MD, of Georgetown University, Washington, DC, discusses the issues involved in the combined blockade of vascular endothelial growth factor (VEGF) and programmed death 1 (PD-1) signaling in renal cell carcinoma (RCC). This video was recorded at the 2019 Genitourinary Cancers Symposium, held in San Francisco, CA.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter